CANDIDO, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 3.085
EU - Europa 1.727
AS - Asia 1.201
SA - Sud America 280
AF - Africa 171
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.469
Nazione #
US - Stati Uniti d'America 2.989
IT - Italia 725
SG - Singapore 629
CN - Cina 387
IE - Irlanda 383
BR - Brasile 265
UA - Ucraina 197
DE - Germania 144
CI - Costa d'Avorio 108
CA - Canada 86
RU - Federazione Russa 80
VN - Vietnam 61
SN - Senegal 36
FI - Finlandia 35
IN - India 35
SE - Svezia 28
GB - Regno Unito 24
FR - Francia 22
NL - Olanda 21
CH - Svizzera 17
AT - Austria 13
BD - Bangladesh 13
KR - Corea 13
TR - Turchia 12
UZ - Uzbekistan 10
ZA - Sudafrica 10
IQ - Iraq 8
NG - Nigeria 8
AR - Argentina 7
IR - Iran 7
MX - Messico 7
PK - Pakistan 7
PL - Polonia 6
GR - Grecia 5
BE - Belgio 4
BG - Bulgaria 4
RO - Romania 4
VE - Venezuela 4
AL - Albania 3
AU - Australia 3
ES - Italia 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
TN - Tunisia 3
CZ - Repubblica Ceca 2
IL - Israele 2
KG - Kirghizistan 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
KI - Kiribati 1
LI - Liechtenstein 1
MA - Marocco 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
Totale 6.469
Città #
Santa Clara 650
Chandler 420
Singapore 380
Dublin 375
Jacksonville 278
Chicago 212
Catania 205
Boardman 151
Abidjan 108
Cambridge 100
Lawrence 100
Andover 91
Grafing 84
Nanjing 82
Toronto 71
Houston 56
Des Moines 55
Wilmington 52
Ashburn 48
Dong Ket 47
Civitanova Marche 43
Beijing 42
Dakar 36
Palermo 31
San Mateo 30
The Dalles 28
Council Bluffs 27
Hebei 27
Nanchang 25
São Paulo 25
Helsinki 23
Rome 22
Saint Petersburg 22
Columbus 20
Hefei 20
Shenyang 19
Jiaxing 16
Falls Church 14
Acireale 13
Bremen 13
Los Angeles 13
Seoul 13
Dearborn 12
Hanoi 12
Naples 12
Padova 12
Ottawa 11
Rio de Janeiro 11
Messina 10
Munich 10
Augusta 9
Belo Horizonte 9
Milan 9
New York 9
Redwood City 9
Tianjin 9
Abuja 8
Aci Catena 8
Jinan 8
Mascalucia 8
Norwalk 8
Changsha 7
Guangzhou 7
Kochi 7
Leawood 7
Den Haag 6
Frankfurt Am Main 6
Lappeenranta 6
Mumbai 6
Redmond 6
Turku 6
Amsterdam 5
Ardabil 5
Baghdad 5
Florence 5
Genoa 5
Johannesburg 5
Maletto 5
Misterbianco 5
Ningbo 5
Nuremberg 5
San Francisco 5
Tashkent 5
Vasto 5
Bari 4
Boston 4
Brussels 4
Campinas 4
Cape Town 4
Edinburgh 4
Guarulhos 4
Istanbul 4
Kunming 4
San Diego 4
Seattle 4
Syracuse 4
Tremestieri Etneo 4
Turin 4
Vienna 4
Zhengzhou 4
Totale 4.464
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 195
Computational modelling in melanoma for novel drug discovery 96
Prognostic significance of deregulated microRNAs in uveal melanomas 93
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 91
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 88
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 86
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 86
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 85
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 85
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 85
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 85
Environment and bladder cancer: Molecular analysis by interaction networks 84
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 83
Cutaneous melanoma: From pathogenesis to therapy 82
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 81
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 81
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 81
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 80
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 80
microRNAs and thyroid cancer: Biological and clinical significance (Review). 79
Advances in targeting signal transduction pathways. 79
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 79
Nitric Oxide in Hematological Cancers: Partner or Rival? 79
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 78
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 77
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 73
Pericytes in microvessels: From “mural” function to brain and retina regeneration 73
Emerging targeted therapies for melanoma treatment (review) 72
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 71
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 70
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 69
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 67
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 66
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 66
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 65
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 64
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 64
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 63
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 63
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 63
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 62
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 62
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 62
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 61
Cutaneous melanoma and the immunotherapy revolution (Review) 61
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 60
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 60
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 59
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 57
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 56
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 55
Targeting signaling pathways involved in metastasis in cancer stem cells 55
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 55
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 55
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 55
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 55
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 54
Suppressing prostate cancer by targeting NGAL 53
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 53
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 51
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 51
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 51
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 50
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 50
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 50
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 49
The tumor microenvironment in hepatocellular carcinoma 49
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 47
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance 47
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 46
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 46
Cancer therapy and treatments during COVID-19 era 46
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 45
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 45
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 45
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 45
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways 45
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 44
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 44
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 44
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 44
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 44
Metformin influences drug sensitivity in pancreatic cancer cells 43
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 43
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 43
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 43
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 42
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 42
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 42
MMP-9 is down-regulated after treatment with Vemurafenib in A375 and A2058 melanoma cells 42
Transcription analysis of Neutral Associated Lipocalin (NGAL) in Hepatocellular Carcinoma 42
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 42
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 41
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 41
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 40
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 40
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines 40
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 39
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy 39
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 39
Totale 6.118
Categoria #
all - tutte 27.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021623 8 31 62 4 107 33 75 0 109 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.652 24 390 143 142 589 286 131 103 210 266 176 192
2025/202644 44 0 0 0 0 0 0 0 0 0 0 0
Totale 6.660